Copyright Reports & Markets. All rights reserved.

Global Live Attenuated Veterinary Vaccines Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Live Attenuated Veterinary Vaccines by Country/Region, 2017, 2022 & 2028
  • 2.2 Live Attenuated Veterinary Vaccines Segment by Type
    • 2.2.1 Poultry
    • 2.2.2 Ruminants
    • 2.2.3 Feline
    • 2.2.4 Canine
  • 2.3 Live Attenuated Veterinary Vaccines Sales by Type
    • 2.3.1 Global Live Attenuated Veterinary Vaccines Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Live Attenuated Veterinary Vaccines Sale Price by Type (2017-2022)
  • 2.4 Live Attenuated Veterinary Vaccines Segment by Application
    • 2.4.1 Veterinary Hospital
    • 2.4.2 Laboratory
    • 2.4.3 CROs
    • 2.4.4 Others
  • 2.5 Live Attenuated Veterinary Vaccines Sales by Application
    • 2.5.1 Global Live Attenuated Veterinary Vaccines Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Live Attenuated Veterinary Vaccines Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Live Attenuated Veterinary Vaccines Sale Price by Application (2017-2022)

3 Global Live Attenuated Veterinary Vaccines by Company

  • 3.1 Global Live Attenuated Veterinary Vaccines Breakdown Data by Company
    • 3.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Company (2020-2022)
    • 3.1.2 Global Live Attenuated Veterinary Vaccines Sales Market Share by Company (2020-2022)
  • 3.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Live Attenuated Veterinary Vaccines Revenue by Company (2020-2022)
    • 3.2.2 Global Live Attenuated Veterinary Vaccines Revenue Market Share by Company (2020-2022)
  • 3.3 Global Live Attenuated Veterinary Vaccines Sale Price by Company
  • 3.4 Key Manufacturers Live Attenuated Veterinary Vaccines Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Live Attenuated Veterinary Vaccines Product Location Distribution
    • 3.4.2 Players Live Attenuated Veterinary Vaccines Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Live Attenuated Veterinary Vaccines by Geographic Region

  • 4.1 World Historic Live Attenuated Veterinary Vaccines Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Geographic Region
  • 4.2 World Historic Live Attenuated Veterinary Vaccines Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Live Attenuated Veterinary Vaccines Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Live Attenuated Veterinary Vaccines Annual Revenue by Country/Region
  • 4.3 Americas Live Attenuated Veterinary Vaccines Sales Growth
  • 4.4 APAC Live Attenuated Veterinary Vaccines Sales Growth
  • 4.5 Europe Live Attenuated Veterinary Vaccines Sales Growth
  • 4.6 Middle East & Africa Live Attenuated Veterinary Vaccines Sales Growth

5 Americas

  • 5.1 Americas Live Attenuated Veterinary Vaccines Sales by Country
    • 5.1.1 Americas Live Attenuated Veterinary Vaccines Sales by Country (2017-2022)
    • 5.1.2 Americas Live Attenuated Veterinary Vaccines Revenue by Country (2017-2022)
  • 5.2 Americas Live Attenuated Veterinary Vaccines Sales by Type
  • 5.3 Americas Live Attenuated Veterinary Vaccines Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Live Attenuated Veterinary Vaccines Sales by Region
    • 6.1.1 APAC Live Attenuated Veterinary Vaccines Sales by Region (2017-2022)
    • 6.1.2 APAC Live Attenuated Veterinary Vaccines Revenue by Region (2017-2022)
  • 6.2 APAC Live Attenuated Veterinary Vaccines Sales by Type
  • 6.3 APAC Live Attenuated Veterinary Vaccines Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Live Attenuated Veterinary Vaccines by Country
    • 7.1.1 Europe Live Attenuated Veterinary Vaccines Sales by Country (2017-2022)
    • 7.1.2 Europe Live Attenuated Veterinary Vaccines Revenue by Country (2017-2022)
  • 7.2 Europe Live Attenuated Veterinary Vaccines Sales by Type
  • 7.3 Europe Live Attenuated Veterinary Vaccines Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Live Attenuated Veterinary Vaccines by Country
    • 8.1.1 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Live Attenuated Veterinary Vaccines Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Type
  • 8.3 Middle East & Africa Live Attenuated Veterinary Vaccines Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Live Attenuated Veterinary Vaccines
  • 10.3 Manufacturing Process Analysis of Live Attenuated Veterinary Vaccines
  • 10.4 Industry Chain Structure of Live Attenuated Veterinary Vaccines

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Live Attenuated Veterinary Vaccines Distributors
  • 11.3 Live Attenuated Veterinary Vaccines Customer

12 World Forecast Review for Live Attenuated Veterinary Vaccines by Geographic Region

  • 12.1 Global Live Attenuated Veterinary Vaccines Market Size Forecast by Region
    • 12.1.1 Global Live Attenuated Veterinary Vaccines Forecast by Region (2023-2028)
    • 12.1.2 Global Live Attenuated Veterinary Vaccines Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Live Attenuated Veterinary Vaccines Forecast by Type
  • 12.7 Global Live Attenuated Veterinary Vaccines Forecast by Application

13 Key Players Analysis

  • 13.1 Zoetis, Inc.
    • 13.1.1 Zoetis, Inc. Company Information
    • 13.1.2 Zoetis, Inc. Live Attenuated Veterinary Vaccines Product Offered
    • 13.1.3 Zoetis, Inc. Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Zoetis, Inc. Main Business Overview
    • 13.1.5 Zoetis, Inc. Latest Developments
  • 13.2 Ceva Santé Animale
    • 13.2.1 Ceva Santé Animale Company Information
    • 13.2.2 Ceva Santé Animale Live Attenuated Veterinary Vaccines Product Offered
    • 13.2.3 Ceva Santé Animale Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Ceva Santé Animale Main Business Overview
    • 13.2.5 Ceva Santé Animale Latest Developments
  • 13.3 Boehringer Ingelheim
    • 13.3.1 Boehringer Ingelheim Company Information
    • 13.3.2 Boehringer Ingelheim Live Attenuated Veterinary Vaccines Product Offered
    • 13.3.3 Boehringer Ingelheim Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Boehringer Ingelheim Main Business Overview
    • 13.3.5 Boehringer Ingelheim Latest Developments
  • 13.4 MSD Animal Health
    • 13.4.1 MSD Animal Health Company Information
    • 13.4.2 MSD Animal Health Live Attenuated Veterinary Vaccines Product Offered
    • 13.4.3 MSD Animal Health Live Attenuated Veterinary Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 MSD Animal Health Main Business Overview
    • 13.4.5 MSD Animal Health Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Live Attenuated Veterinary Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Live Attenuated Veterinary Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Live Attenuated Veterinary Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Live Attenuated Veterinary Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Live Attenuated Veterinary Vaccines market, reaching US$ million by the year 2028. As for the Europe Live Attenuated Veterinary Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Live Attenuated Veterinary Vaccines players cover Zoetis, Inc., Ceva Santé Animale, Boehringer Ingelheim, and MSD Animal Health, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Veterinary Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Poultry
Ruminants
Feline
Canine

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Veterinary Hospital
Laboratory
CROs
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Zoetis, Inc.
Ceva Santé Animale
Boehringer Ingelheim
MSD Animal Health
Buy now